2021 AGA临床实践指南：肝硬化患者凝血障碍的管理

2021-09-24 美国胃肠病协会 Gastroenterology

2021年9月，美国胃肠病协会(AGA)发布了肝硬化患者凝血障碍的管理指南。肝硬化是一种伴随着实验室参数显著改变的疾病状态，如血小板计数和凝血酶原时间/国际标准化比值（PT/INR）通常用于评估凝血功

中文标题：

英文标题：

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

发布机构：

美国胃肠病协会

发布日期：

2021-09-24

简要介绍：

2021年9月，美国胃肠病协会(AGA)发布了肝硬化患者凝血障碍的管理指南。肝硬化是一种伴随着实验室参数显著改变的疾病状态，如血小板计数和凝血酶原时间/国际标准化比值（PT/INR）通常用于评估凝血功能。本文主要针对肝硬化患者凝血障碍的管理提供指导建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=f79501c0021961b9, title=2021 AGA临床实践指南：肝硬化患者凝血障碍的管理, enTitle=AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis, guiderFrom=Gastroenterology, authorId=0, author=, summary=2021年9月，美国胃肠病协会(AGA)发布了肝硬化患者凝血障碍的管理指南。肝硬化是一种伴随着实验室参数显著改变的疾病状态，如血小板计数和凝血酶原时间/国际标准化比值（PT/INR）通常用于评估凝血功, cover=https://img.medsci.cn/2021929/1632892609952_5579292.jpg, journalId=0, articlesId=null, associationId=102, associationName=美国胃肠病协会, associationIntro=美国胃肠病协会成立于1897年,已包括来自全球各地17000个成员参与消化所有方面的研究、实践和前沿。提供各项关于胃肠道疾病的指南和研究，发布两本期刊，都为月刊，每年5月份会举行年会。, copyright=0, guiderPublishedTime=Fri Sep 24 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年9月，美国胃肠病协会(AGA)发布了肝硬化患者凝血障碍的管理指南。肝硬化是一种伴随着实验室参数显著改变的疾病状态，如血小板计数和凝血酶原时间/国际标准化比值（PT/INR）通常用于评估凝血功能。本文主要针对肝硬化患者凝血障碍的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=492, tagName=肝硬化)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=492, guiderKeyword=肝硬化, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15710, appHits=141, showAppHits=0, pcHits=747, showPcHits=15569, likes=3, shares=20, comments=6, approvalStatus=1, publishedTime=Wed Sep 29 13:19:26 CST 2021, publishedTimeString=2021-09-24, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Sep 29 13:19:20 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 16:09:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AGA临床实践指南：肝硬化患者凝血障碍的管理.pdf)])

2021 AGA临床实践指南：肝硬化患者凝血障碍的管理.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1182111, encodeId=4c6a11821116b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:39 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182110, encodeId=fcab1182110ef, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:24 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061883, encodeId=4a991061883e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:56 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059608, encodeId=43aa105960882, content=谢谢啦！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B2E32AADADB9BC1CB20C2DE54D782551/100, createdBy=eaa72465761, createdName=皮彪, createdTime=Mon Oct 11 23:21:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056572, encodeId=cd5f10565e2c0, content=与时俱进, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:38:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
2022-01-08 ms2000001396659603

学习了

41 0
[GetPortalCommentsPageByObjectIdResponse(id=1182111, encodeId=4c6a11821116b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:39 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182110, encodeId=fcab1182110ef, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:24 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061883, encodeId=4a991061883e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:56 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059608, encodeId=43aa105960882, content=谢谢啦！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B2E32AADADB9BC1CB20C2DE54D782551/100, createdBy=eaa72465761, createdName=皮彪, createdTime=Mon Oct 11 23:21:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056572, encodeId=cd5f10565e2c0, content=与时俱进, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:38:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
2022-01-08 ms2000001396659603

学习了

53 0
[GetPortalCommentsPageByObjectIdResponse(id=1182111, encodeId=4c6a11821116b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:39 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182110, encodeId=fcab1182110ef, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:24 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061883, encodeId=4a991061883e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:56 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059608, encodeId=43aa105960882, content=谢谢啦！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B2E32AADADB9BC1CB20C2DE54D782551/100, createdBy=eaa72465761, createdName=皮彪, createdTime=Mon Oct 11 23:21:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056572, encodeId=cd5f10565e2c0, content=与时俱进, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:38:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
2021-10-19 湘雅科教

不错

117 0
[GetPortalCommentsPageByObjectIdResponse(id=1182111, encodeId=4c6a11821116b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:39 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182110, encodeId=fcab1182110ef, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:24 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061883, encodeId=4a991061883e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:56 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059608, encodeId=43aa105960882, content=谢谢啦！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B2E32AADADB9BC1CB20C2DE54D782551/100, createdBy=eaa72465761, createdName=皮彪, createdTime=Mon Oct 11 23:21:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056572, encodeId=cd5f10565e2c0, content=与时俱进, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:38:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
2021-10-11 皮彪

谢谢啦！谢谢

124 0
[GetPortalCommentsPageByObjectIdResponse(id=1182111, encodeId=4c6a11821116b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:39 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182110, encodeId=fcab1182110ef, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:51:24 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061883, encodeId=4a991061883e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:56 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059608, encodeId=43aa105960882, content=谢谢啦！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B2E32AADADB9BC1CB20C2DE54D782551/100, createdBy=eaa72465761, createdName=皮彪, createdTime=Mon Oct 11 23:21:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056572, encodeId=cd5f10565e2c0, content=与时俱进, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:38:08 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
2021-09-30 13f0c37dm61暂无昵称

与时俱进

123 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

血液科指南

2021 AGA临床实践指南：肝硬化患者凝血障碍的管理

相关指南

拓展阅读

科室

工具

服务